King Wealth Management Group - PROTAGONIST THERAPEUTICS INC ownership

PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 145 filers reported holding PROTAGONIST THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.

Quarter-by-quarter ownership
King Wealth Management Group ownership history of PROTAGONIST THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$200
-39.6%
12,0000.0%0.04%
-37.3%
Q2 2023$331
+19.9%
12,0000.0%0.07%
+9.8%
Q1 2023$276
+15.0%
12,000
-45.5%
0.06%
+7.0%
Q4 2022$240
-99.9%
22,0000.0%0.06%
+21.3%
Q3 2022$185,000
+6.3%
22,0000.0%0.05%
+11.9%
Q2 2022$174,000
-66.6%
22,0000.0%0.04%
-58.8%
Q1 2022$521,000
-30.7%
22,0000.0%0.10%
-27.1%
Q4 2021$752,000
+92.8%
22,0000.0%0.14%
+75.0%
Q3 2021$390,000
-60.5%
22,0000.0%0.08%
-60.4%
Q2 2021$987,000
+73.2%
22,0000.0%0.20%
+57.8%
Q1 2021$570,000
+28.4%
22,0000.0%0.13%
+23.1%
Q4 2020$444,000
+3.3%
22,0000.0%0.10%
-7.1%
Q3 2020$430,000
+10.5%
22,0000.0%0.11%
-1.8%
Q2 2020$389,000
+151.0%
22,0000.0%0.11%
+70.1%
Q1 2020$155,0000.0%22,0000.0%0.07%
+63.4%
Q4 2019$155,000
-24.0%
22,000
+29.4%
0.04%
-30.5%
Q3 2019$204,000
-1.0%
17,0000.0%0.06%
-4.8%
Q2 2019$206,000
-15.9%
17,000
-12.8%
0.06%
-19.5%
Q1 2019$245,000
+25.6%
19,500
-32.8%
0.08%
+8.5%
Q4 2018$195,00029,0000.07%
Other shareholders
PROTAGONIST THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 2,449,183$20,647,0006.08%
Bain Capital Life Sciences Investors, LLC 2,260,572$19,057,0002.28%
Kynam Capital Management, LP 519,212$4,377,0000.92%
RTW INVESTMENTS, LP 4,176,837$35,211,0000.81%
Tri Locum Partners LP 199,500$1,682,0000.46%
Birchview Capital, LP 38,000$320,0000.22%
Gratus Capital, LLC 206,113$1,738,0000.18%
FARALLON CAPITAL MANAGEMENT LLC 3,651,887$30,785,0000.17%
PDT Partners, LLC 126,038$1,063,0000.16%
FOX RUN MANAGEMENT, L.L.C. 40,683$343,0000.13%
View complete list of PROTAGONIST THERAPEUTICS INC shareholders